FRI0317 Act-Axis Study: Impact of Roactemra® (TOCILIZUMAB) on Fatigue and Related Factors in Patients with Arthritis Rheumatoid in Daily Clinical Practice in Spain

H. Corominas; C. Alegre de Miguel; M. Rodríguez-Gόmez; C. Marras Fernandez-Cid; F. Maceiras-Pan

doi:10.1136/annrheumdis-2014-eular.1509

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

EULAR 2014: Scientific Abstracts

Poster Presentations. Rheumatoid arthritis - other biologic treatment

FRI0317 Act-Axis Study: Impact of Roactemra® (TOCILIZUMAB) on Fatigue and Related Factors in Patients with Arthritis Rheumatoid in Daily Clinical Practice in Spain

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password